87 related articles for article (PubMed ID: 8450017)
1. Normal-phase high-performance liquid chromatographic determination of epristeride, a prostatic steroid 5 alpha-reductase enzyme inhibitor, in human plasma.
Boppana VK; Miller-Stein C; Rhodes GR
J Chromatogr; 1993 Feb; 631(1-2):251-4. PubMed ID: 8450017
[TBL] [Abstract][Full Text] [Related]
2. Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2.
Levy MA; Brandt M; Sheedy KM; Dinh JT; Holt DA; Garrison LM; Bergsma DJ; Metcalf BW
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):197-206. PubMed ID: 8142295
[TBL] [Abstract][Full Text] [Related]
3. Column-switching high-performance liquid chromatographic method for the determination of SK&F 106203 in human plasma after fluorescence derivatization with 9-anthryldiazomethane.
Miller-Stein C; Hwang BY; Rhodes GR; Boppana VK
J Chromatogr; 1993 Feb; 631(1-2):233-40. PubMed ID: 8450016
[TBL] [Abstract][Full Text] [Related]
4. Determination of exemestane, a new aromatase inhibitor, in plasma by high-performance liquid chromatography with ultraviolet detection.
Breda M; Pianezzola E; Benedetti MS
J Chromatogr; 1993 Oct; 620(2):225-31. PubMed ID: 8300790
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic determination of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a 4-azasteroid, in human plasma from a phase I study.
Carlin JR; Christofalo P; Vandenheuvel WJ
J Chromatogr; 1988 May; 427(1):79-91. PubMed ID: 2842353
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new 5 alpha reductase inhibitor (epristeride) on human prostate cell cultures.
Robinson EJ; Collins AT; Robson CN; Neal DE
Prostate; 1997 Sep; 32(4):259-65. PubMed ID: 9288184
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.
Benincosa LJ; Audet PR; Lundberg D; Zariffa N; Jorkasky DK
Biopharm Drug Dispos; 1996 Apr; 17(3):249-58. PubMed ID: 8983399
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses.
Constanzer ML; Matuszewski BK; Bayne WF
J Chromatogr; 1991 May; 566(1):127-34. PubMed ID: 1653258
[TBL] [Abstract][Full Text] [Related]
9. Reversible long-term toxicity of epristeride in beagle dogs.
Sun ZY; Feng J; Qi XD; Wu HY; Zheng WJ; Tu ZH
Toxicol Appl Pharmacol; 1999 Jan; 154(2):145-52. PubMed ID: 9925798
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of granisetron and its 7-hydroxy metabolite in human plasma by reversed-phase high-performance liquid chromatography utilizing fluorescence and electrochemical detection.
Boppana VK
J Chromatogr A; 1995 Feb; 692(1-2):195-202. PubMed ID: 7719453
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective determination of the enantiomers of methadone in plasma using high-performance liquid chromatography.
Schmidt N; Brune K; Geisslinger G
J Chromatogr; 1992 Dec; 583(2):195-200. PubMed ID: 1478983
[TBL] [Abstract][Full Text] [Related]
12. Sensitive high-performance liquid chromatographic method for determination of captopril in plasma.
Amini M; Zarghi A; Vatanpour H
Pharm Acta Helv; 1999 Jun; 73(6):303-6. PubMed ID: 10443174
[TBL] [Abstract][Full Text] [Related]
13. Determination of a novel hematoregulatory peptide in dog plasma by reversed-phase high-performance liquid chromatography and an amine-selective o-phthaldialdehyde-thiol post-column reaction with fluorescence detection.
Boppana VK; Miller-Stein C
J Chromatogr A; 1994 Jul; 676(1):161-7. PubMed ID: 7921173
[TBL] [Abstract][Full Text] [Related]
14. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of the N-ethyl tricarbamate ester pro-drug of fenoldopam utilizing simultaneous post-column hydrolysis and fluorescence derivatization.
Miller-Stein C; Boppana VK; Rhodes GR
J Chromatogr B Biomed Appl; 1994 Nov; 661(2):291-7. PubMed ID: 7894669
[TBL] [Abstract][Full Text] [Related]
16. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors.
Higashiura K; Blaney B; Morgan E; Mathur RS; Halushka PV
J Pharmacol Exp Ther; 1996 Dec; 279(3):1386-91. PubMed ID: 8968363
[TBL] [Abstract][Full Text] [Related]
18. [Validity of a liquid chromatographic (HPLC) method for the determination of ticlopidine in human plasma].
Róna K; Ary K; Gachályi B; Klebovich I
Acta Pharm Hung; 1997 Jan; 67(1):25-9. PubMed ID: 9163256
[TBL] [Abstract][Full Text] [Related]
19. High performance liquid chromatographic method for the determination of cetirizine and ambroxol in human plasma and urine--a boxcar approach.
Dharuman J; Vasudhevan M; Ajithlal T
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2624-31. PubMed ID: 21840269
[TBL] [Abstract][Full Text] [Related]
20. Sensitive determination of clarithromycin in human plasma by high-performance liquid chromatography with spectrophotometric detection.
Amini H; Ahmadiani A
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):193-7. PubMed ID: 15686985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
